Page 661 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 29 Tumors of the Male Reproductive System 639

77. Peters MAJ, Jong FS, Teerds KJ, et al.: Ageing, testicular 99. Yu CH, Hwang DN, Kim JH, et al.: Comparative immunohis-
tumours and the pituitary-testis axis in dogs, J Endocrinol 166: tochemical characterization of canine seminomas and Sertoli cell
153–161, 2000. tumors, J Vet Sci 10:1–7, 2009.
VetBooks.ir 78. Taniyama H, Hirayama K, Nakada K, et al.: Immunohistochemical 100. Doxsee AL, Yager JA, Best SJ, et al.: Extratesticular interstitial and
Sertoli cell tumors in previously neutered dogs and cats: a report of
detection of inhibin-alpha, -betaB, and -betaA chains and 3beta-
hydroxysteroid dehydrogenase in canine testicular tumors and nor-
17 cases, Can Vet J 47:763–766, 2006.
mal testes, Vet Pathol 38:661–666, 2001. 101. Archbald LI, Waldow D, Gelatt K: Interstitial cell tumor, J Am Vet
79. Grootenhuis AJ, vanSluijs FJ, Klaij IA, et al.: Inhibin, gonadotro- Med Assoc 210:1423–1424, 1997.
phins and sex steroids in dogs with Sertoli cell tumours, J Endocri- 102. England GC: Ultrasonographic diagnosis of non-palpable Sertoli
nol 127:235–242, 1990. cell tumours in infertile dogs, J Sm An Pract 36:476–480, 1995.
80. Peters MA, Mol JA, vanWolferen Me, et al.: Expression of the 103. Metzger FL, Hattel AL: Hematuria, hyperestrogenemia, and hyper-
insulin-like growth factor (IGF) system and steroidogenic progesteronemia due to a sertoli-cell tumor in a bilaterally cryptor-
enzymes in canine testis tumors, Reprod Biol Endocrinol 14: chid dog, Canine Pract 18:32–35, 1993.
22–29, 2003. 104. Madewell BR, Theilen GH: Tumors of the genital tract. In Theilen
81. Holst BS, Dreimanis U: Anti-Mullerian hormone: a potentially GH, Madewell BR, editors: Veterinary cancer medicine, ed 2, Phila-
useful biomarker for the diagnosis of canine Sertoli cell tumours, delphia, 1987, Lea & Febiger, pp 583–600.
BMC Vet Res 11:166, 2015. 105. McDonald RK, Walker M, Legendre A, et al.: Radiotherapy of
82. Roly ZY, Backhouse B, Cutting A, et al.: The cell biology and metastatic seminoma in the dog. Case reports, J Vet Intern Med
molecular genetics of Mullerian duct development, Wiley Interdiscip 2:103–107, 1988.
Rev Dev Biol 7:e310, 2018. 106. Albers P, Albrecht W, Algaba F, et al.: EAU guidelines on testicular
83. Sherding RG, Wilson GP, Kociba GJ: Bone marrow hypoplasia in cancer: 2011 update, Eur Uol 60:304–319, 2011.
eight dogs with Sertoli cell tumor, J Am Vet Med Assoc 178:497– 107. Rosen DK, Carpenter JL: Functional ectopic interstitial cell tumor
501, 1981. in a castrated male cat, J Am Vet Med Assoc 202:1865–1866, 1993.
84. Scott DW, Reimers TJ: Tail gland and perianal gland hyperplasia 108. Cotchin E: Neoplasia. In Wilkinson GT, editor: Diseases of the cat
associated with testicular neoplasia and hypertestosteronemia in a and their management, Oxford, 1984, Blackwell, pp 366–387.
dog, Canine Pract 13:15–17, 1986. 109. Miller MA, Hartnett SE, Ramos-Vara JA: Interstitial cell tumor and
85. Laing EJ, Harari J, Smith CW: Spermatic cord torsion and Sertoli Sertoli cell tumor in the testis of a cat, Vet Pathol 44:394–397, 2007.
cell tumor in a dog, J Am Vet Med Assoc 183:879–881, 1983. 110. Miyoshi N, Yasuda N, Kamimura Y, et al.: Teratoma in a feline
86. Spackman CJ, Roth L: Prostatic cyst and concurrent Sertoli cell unilateral cryptorchid testis, Vet Pathol 38:729–730, 2001.
tumor in a dog, J Am Vet Med Assoc 192:1096–1098, 1988. 111. Ferreira-da-Silva J: Teratoma in a feline unilateral cryptorchid testis
87. Barrand KR, Scudamore CL: Canine hypertrophic osteoarthrop- (letter to the editor), Vet Pathol 39:516, 2002.
athy associated with a malignant Sertoli cell tumour, J Sm Anim 112. Benazzi C, Sarli G, Brunetti B: Sertoli cell tumour in a cat, J Vet
Pract 42:143–145, 2001. Med A Physiol Pathol Clin Med 51:124–126, 2004.
88. Brown TT, Burek JD, McEntee K: Male pseudohermaphroditism, 113. Meier H: Sertoli-cell tumor in the cat. Report of two cases, North
cryptorchism, and Sertoli cell neoplasia in three miniature Schnau- Am Vet 37:979–981, 1956.
zers, J Am Vet Med Assoc 169:821–825, 1976. 114. Rosen A, Jayram G, Drazer M, et al.: Global trends in
89. Norrdin RW, Baum AC: A male pseudohermaphrodite dog with a testicular cancer incidence and mortality, Eur Urol 60:
Sertoli’s cell tumor, mucometra, and vaginal glands, J Am Vet Med 374–379, 2011.
Assoc 156:204–207, 1970. 115. Ruf CG, Isbarn H, Wagner W, et al.: Changes in epidemiologic
90. Frey DC, Tyler DE, Ramsey FK: Pyometra associated with bilateral features of testicular germ cell cancer: age at diagnosis and relative
cryptorchidism and Sertoli’s cell tumor in a male pseudohermaph- frequency of seminoma are constantly and significantly increasing,
roditic dog, J Am Vet Med Assoc 146:723–727, 1965. Urol Oncol 32(33):e31–e36, 2014.
91. Park EJ, Lee SH, Jo YK, et al.: Coincidence of Persistent Mullerian 116. Motzer RJ, Jonasch E, Agarwal N, et al.: Testicular cancer, version
duct syndrome and testicular tumors in dogs, BMC Vet Res 13:156, 2.2015, J Natl Compr Canc Netw 13:772–799, 2015.
2017. 117. Jacobsen R, Moller H, Thoresen S, et al.: Trends in testicular cancer
92. Bigliardi E, Parma P, Peressotti P, et al.: Clinical, genetic, and path- incidence in the Nordic countries, focusing on the recent decrease
ological features of male pseudohermaphroditism in dog, Reprod in Denmark, Int J Androl 29:199–204, 2006.
Biol Endocrinol 9:12–18, 2011. 118. Myrup C, Wohlfahrt J, Oudin A, et al.: Risk of testicular cancer
93. Johnston GR, Feeney DA, Johnston SD, et al.: Ultrasonographic according to brithplace and birth cohort in Denmark, Int J Cancer
features of testicular neoplasia in dogs: 16 cases (1980-1988), J Am 126:217–223, 2010.
Vet Med Assoc 198:1779–1784, 1991. 119. Henderson BE, Benton B, Jing J, et al.: Risk factors for cancer of
94. Pugh CR, Konde LJ: Sonographic evaluation of canine testicular the testis in young men, Int J Cancer 23:598–602, 1979.
and scrotal abnormalities: a review of 26 case histories, Vet Radiol 120. Weir HK, Marrett LD, Kreiger N, Darlington GA: Pre-natal and
32:243–250, 1991. peri-natal exposures and risk of testicular germ-cell cancer, Int J
95. Eilts BE, Pechman RD, Hedlund CS, et al.: Use of ultrasonography Cancer 87:438–443, 2000.
to diagnose Sertoli cell neoplasia and cryptorchidism in a dog, J Am 121. Garner MJ, Birkett NJ, Johnson KC, et al.: Dietary risk factors for
Vet Med Assoc 192:533–534, 1988. testicular carcinoma, Int J Cancer 106:934–941, 2003.
96. Masserdotti C, DeLorenzi D, Gasparotto L: Cytologic detection 122. Hu J, LaVecchia C, Morrison H, et al.: Salt, processed meta and the
of Call-Exner bodies in Sertoli cell tumors from 2 dogs, Vet Clin risk of cancer, Eur J Cancer Prev 20:132–139, 2011.
Pathol 37:112–114, 2008. 123. Kratz CP, Mai PL, Greene MH: Familial testicular germ
97. Banco B, Giudice C, Veronesi MC, et al.: An immunohistochemi- cell tumours, Best Pract Res Clin Endocrinol Metab 24:
cal study of normal and neoplastic canine sertoli cells, J Comp 503–513, 2010.
Pathol 143:239–247, 2010. 124. VandenEeden SK, Weiss NS, Strader CH, et al.: Occupa-
98. Peters MA, Teerds KJ, vanderGaag I, et al.: Use of antibodies against tion and the occurrence of testicular cancer, Am J Ind Med 19:
LH receptor, 3beta-hydroxysteroid dehydrogenase and vimentin to 327–337, 1991.
characterize different types of testicular tumour in dogs, Reproduc- 125. Garner MJ, Turner MC, Ghadirian P, et al.: Epidemiology of tes-
tion 121:287–296, 2001. ticular cancer: an overview, Int J Cancer 116:331–339, 2005.